A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication

Background: Early differentiation between transient ischemic attack (TIA) and minor ischemic stroke (MIS) impacts on the patient's individual diagnostic work-up and treatment. Furthermore, estimations regarding persisting impairments after MIS are essential to guide rehabilitation programs. Thi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Johann Otto Pelz, Katharina Kubitz, Manja Kamprad-Lachmann, Kristian Harms, Martin Federbusch, Carsten Hobohm, Dominik Michalski
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	biomarker panel minor ischemic stroke transient ischemic attack prognostication functional impairment Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/69a2cf70457e454fb544031d12793291
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication

Ejemplares similares